Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Report 2023

Publication ID:

PB501231826

Publication Date:

January 2, 2023

Pages:

132

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or 鈥渓ot鈥� of Intravenous Immunoglobulin.
麻豆原创 Analysis and Insights: Global Intravenous Immunoglobulin (IVIg) 麻豆原创
Due to the COVID-19 pandemic, the global Intravenous Immunoglobulin (IVIg) market size is estimated to be worth US$ 10310 million in 2022 and is forecast to a readjusted size of US$ 15470 million by 2029 with a CAGR of 5.9% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, IVIg Liquid accounting for % of the Intravenous Immunoglobulin (IVIg) global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Immunodeficiency segment is altered to an % CAGR throughout this forecast period.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
Global Intravenous Immunoglobulin (IVIg) Scope and 麻豆原创 Size
The global Intravenous Immunoglobulin (IVIg) market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Intravenous Immunoglobulin (IVIg) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Intravenous Immunoglobulin (IVIg) 麻豆原创 Overview
1.1 Intravenous Immunoglobulin (IVIg) Product Scope
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2018 & 2022 & 2029)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Comparison by Application (2018 & 2022 & 2029)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Intravenous Immunoglobulin (IVIg) 麻豆原创 Estimates and Forecasts (2018-2029)
1.4.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size in Value Growth Rate (2018-2029)
1.4.2 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size in Volume Growth Rate (2018-2029)
1.4.3 Global Intravenous Immunoglobulin (IVIg) Price Trends (2018-2029)
2 Intravenous Immunoglobulin (IVIg) Estimates and Forecasts by Region
2.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2 Global Intravenous Immunoglobulin (IVIg) Retrospective 麻豆原创 Scenario by Region (2018-2023)
2.2.1 Global Intravenous Immunoglobulin (IVIg) Sales 麻豆原创 Share by Region (2018-2023)
2.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue 麻豆原创 Share by Region (2018-2023)
2.3 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Estimates and Forecasts by Region (2024-2029)
2.3.1 Global Intravenous Immunoglobulin (IVIg) Sales Estimates and Forecasts by Region (2024-2029)
2.3.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2024-2029)
2.4 Geographic 麻豆原创 Analysis: 麻豆原创 Facts & Figures
2.4.1 United States Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
2.4.2 Europe Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
2.4.3 China Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
2.4.4 Japan Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
2.4.5 Southeast Asia Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
2.4.6 India Intravenous Immunoglobulin (IVIg) Estimates and Projections (2018-2029)
3 Global Intravenous Immunoglobulin (IVIg) Competition Landscape by Players
3.1 Global Top Intravenous Immunoglobulin (IVIg) Players by Sales (2018-2023)
3.2 Global Top Intravenous Immunoglobulin (IVIg) Players by Revenue (2018-2023)
3.3 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2022)
3.4 Global Intravenous Immunoglobulin (IVIg) Average Price by Company (2018-2023)
3.5 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Historic 麻豆原创 Review by Type (2018-2023)
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Type (2018-2023)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Type (2018-2023)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Type (2018-2023)
4.2 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Estimates and Forecasts by Type (2024-2029)
4.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Type (2024-2029)
4.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Type (2024-2029)
4.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Type (2024-2029)
5 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Historic 麻豆原创 Review by Application (2018-2023)
5.1.1 Global Intravenous Immunoglobulin (IVIg) Sales by Application (2018-2023)
5.1.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Application (2018-2023)
5.1.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2018-2023)
5.2 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Estimates and Forecasts by Application (2024-2029)
5.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Forecast by Application (2024-2029)
5.2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Application (2024-2029)
5.2.3 Global Intravenous Immunoglobulin (IVIg) Price Forecast by Application (2024-2029)
6 United States Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
6.1 United States Intravenous Immunoglobulin (IVIg) Sales by Company
6.1.1 United States Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
6.1.2 United States Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
6.2 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
6.2.1 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
6.2.2 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
6.3 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
6.3.1 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
6.3.2 United States Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
7 Europe Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
7.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company
7.1.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
7.1.2 Europe Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
7.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
7.2.1 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
7.2.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
7.3 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
7.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
7.3.2 Europe Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
8 China Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
8.1 China Intravenous Immunoglobulin (IVIg) Sales by Company
8.1.1 China Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
8.1.2 China Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
8.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
8.2.1 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
8.2.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
8.3 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
8.3.1 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
8.3.2 China Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
9 Japan Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
9.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company
9.1.1 Japan Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
9.1.2 Japan Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
9.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
9.2.1 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
9.2.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
9.3 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
9.3.1 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
9.3.2 Japan Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
10 Southeast Asia Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
10.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company
10.1.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
10.1.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
10.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
10.2.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
10.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
10.3.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
11 India Intravenous Immunoglobulin (IVIg) 麻豆原创 Facts & Figures
11.1 India Intravenous Immunoglobulin (IVIg) Sales by Company
11.1.1 India Intravenous Immunoglobulin (IVIg) Sales by Company (2018-2023)
11.1.2 India Intravenous Immunoglobulin (IVIg) Revenue by Company (2018-2023)
11.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type
11.2.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2018-2023)
11.2.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Type (2024-2029)
11.3 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application
11.3.1 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2018-2023)
11.3.2 India Intravenous Immunoglobulin (IVIg) Sales Breakdown by Application (2024-2029)
12 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Baxter Intravenous Immunoglobulin (IVIg) Products Offered
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Grifols Intravenous Immunoglobulin (IVIg) Products Offered
12.2.5 Grifols Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.3.4 CSL Intravenous Immunoglobulin (IVIg) Products Offered
12.3.5 CSL Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Products Offered
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Corporation Information
12.5.2 Biotest Business Overview
12.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.5.4 Biotest Intravenous Immunoglobulin (IVIg) Products Offered
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Corporation Information
12.6.2 Kedrion Business Overview
12.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Products Offered
12.6.5 Kedrion Recent Development
12.7 Hualan Bio
12.7.1 Hualan Bio Corporation Information
12.7.2 Hualan Bio Business Overview
12.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Products Offered
12.7.5 Hualan Bio Recent Development
12.8 CNBG
12.8.1 CNBG Corporation Information
12.8.2 CNBG Business Overview
12.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.8.4 CNBG Intravenous Immunoglobulin (IVIg) Products Offered
12.8.5 CNBG Recent Development
12.9 Shanghai RAAS
12.9.1 Shanghai RAAS Corporation Information
12.9.2 Shanghai RAAS Business Overview
12.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Products Offered
12.9.5 Shanghai RAAS Recent Development
12.10 CBPO
12.10.1 CBPO Corporation Information
12.10.2 CBPO Business Overview
12.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.10.4 CBPO Intravenous Immunoglobulin (IVIg) Products Offered
12.10.5 CBPO Recent Development
12.11 LFB Group
12.11.1 LFB Group Corporation Information
12.11.2 LFB Group Business Overview
12.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Products Offered
12.11.5 LFB Group Recent Development
12.12 BPL
12.12.1 BPL Corporation Information
12.12.2 BPL Business Overview
12.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.12.4 BPL Intravenous Immunoglobulin (IVIg) Products Offered
12.12.5 BPL Recent Development
12.13 Sichuan Yuanda Shuyang
12.13.1 Sichuan Yuanda Shuyang Corporation Information
12.13.2 Sichuan Yuanda Shuyang Business Overview
12.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2018-2023)
12.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Products Offered
12.13.5 Sichuan Yuanda Shuyang Recent Development
13 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
13.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
13.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
14 麻豆原创ing Channel, Distributors and Customers
14.1 麻豆原创ing Channel
14.2 Intravenous Immunoglobulin (IVIg) Distributors List
14.3 Intravenous Immunoglobulin (IVIg) Customers
15 麻豆原创 Dynamics
15.1 Intravenous Immunoglobulin (IVIg) Industry Trends
15.2 Intravenous Immunoglobulin (IVIg) 麻豆原创 Drivers
15.3 Intravenous Immunoglobulin (IVIg) 麻豆原创 Challenges
15.4 Intravenous Immunoglobulin (IVIg) 麻豆原创 Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

Companies Mentioned:

Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.